TreeWAS – Variant ID: rs267567

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.465	0.535	0.000
F31 Bipolar affective disorder	0.456	0.544	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.433	0.567	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.400	0.600	0.000
F31.8 Other bipolar affective disorders	0.387	0.613	0.000
F31.9 Bipolar affective disorder, unspecified	0.372	0.628	0.000
F31.7 Bipolar affective disorder, currently in remission	0.359	0.641	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.341	0.659	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.336	0.664	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.326	0.674	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.313	0.687	0.000
F30-F39 Mood [affective] disorders	0.077	0.923	0.000
F30 Manic episode	0.062	0.937	0.000
F38 Other mood [affective] disorders	0.059	0.941	0.000
F30.0 Hypomania	0.058	0.942	0.000
F34 Persistent mood [affective] disorders	0.057	0.943	0.000
F39 Unspecified mood [affective] disorder	0.053	0.947	0.000
F38.8 Other specified mood [affective] disorders	0.046	0.954	0.000
F30.8 Other manic episodes	0.045	0.955	0.000
F34.1 Dysthymia	0.044	0.956	0.000
F38.1 Other recurrent mood [affective] disorders	0.042	0.958	0.000
F38.0 Other single mood [affective] disorders	0.042	0.958	0.000
F30.9 Manic episode, unspecified	0.042	0.958	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.041	0.959	0.000
F34.8 Other persistent mood [affective] disorders	0.041	0.959	0.000
F30.1 Mania without psychotic symptoms	0.040	0.960	0.000
F34.0 Cyclothymia	0.040	0.960	0.000
F30.2 Mania with psychotic symptoms	0.037	0.963	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.030	0.970	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.028	0.972	0.000
F33 Recurrent depressive disorder	0.027	0.973	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.027	0.973	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.027	0.973	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.025	0.974	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.025	0.975	0.000
T43.2 Other and unspecified antidepressants	0.025	0.975	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.024	0.976	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.024	0.976	0.000
T43.6 Psychostimulants with abuse potential	0.024	0.976	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.023	0.976	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.023	0.977	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.023	0.977	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.022	0.977	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.022	0.978	0.000
T36 Poisoning by systemic antibiotics	0.022	0.978	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.022	0.978	0.000
T40.4 Other synthetic narcotics	0.022	0.978	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.022	0.978	0.000
T43.9 Psychotropic drug, unspecified	0.022	0.978	0.000
T42.4 Benzodiazepines	0.022	0.978	0.000
T38.0 Glucocorticoids and synthetic analogues	0.022	0.978	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.022	0.978	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.022	0.978	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.022	0.978	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.021	0.979	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.021	0.979	0.000
T38.5 Other oestrogens and progestogens	0.021	0.979	0.000
T50.4 Drugs affecting uric acid metabolism	0.021	0.979	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.021	0.979	0.000
F33.8 Other recurrent depressive disorders	0.021	0.979	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.020	0.980	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.020	0.980	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.020	0.980	0.000
T38.9 Other and unspecified hormone antagonists	0.019	0.981	0.000
T38.7 Androgens and anabolic congeners	0.019	0.981	0.000
T38.4 Oral contraceptives	0.019	0.981	0.000
T38.2 Antithyroid drugs	0.019	0.981	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.019	0.981	0.000
T39.4 Antirheumatics, not elsewhere classified	0.019	0.981	0.000
T39.2 Pyrazolone derivatives	0.019	0.981	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.019	0.981	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.019	0.981	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.019	0.981	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.019	0.981	0.000
T42.3 Barbiturates	0.019	0.981	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.019	0.981	0.000
T50.7 Analeptics and opioid receptor antagonists	0.018	0.981	0.000
T50.5 Appetite depressants	0.018	0.981	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.018	0.981	0.000
T50.1 Loop [high-ceiling] diuretics	0.018	0.981	0.000
T50.0 Mineralocorticoids and their antagonists	0.018	0.981	0.000
T38.1 Thyroid hormones and substitutes	0.018	0.982	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.018	0.982	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.018	0.982	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.018	0.982	0.000
T50.8 Diagnostic agents	0.018	0.982	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.018	0.982	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.018	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.018	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.018	0.982	0.000
T44.0 Anticholinesterase agents	0.018	0.982	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.018	0.982	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.018	0.982	0.000
T36.8 Other systemic antibiotics	0.017	0.982	0.000
T45.0 Antiallergic and antiemetic drugs	0.018	0.982	0.000
T36.4 Tetracyclines	0.017	0.982	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.017	0.983	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.017	0.983	0.000
T42.2 Succinimides and oxazolidinediones	0.017	0.983	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.017	0.983	0.000
T48.5 Anti-common-cold drugs	0.017	0.983	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.017	0.983	0.000
T48.4 Expectorants	0.017	0.983	0.000
T48.3 Antitussives	0.017	0.983	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.017	0.983	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.017	0.983	0.000
T48.0 Oxytocic drugs	0.017	0.983	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.017	0.983	0.000
T42.0 Hydantoin derivatives	0.017	0.983	0.000
T47.0 Histamine H(2)-receptor antagonists	0.017	0.983	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.017	0.983	0.000
T49.9 Topical agent, unspecified	0.016	0.983	0.000
T49.8 Other topical agents	0.016	0.983	0.000
T49.7 Dental drugs, topically applied	0.016	0.983	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.016	0.983	0.000
T49.5 Ophthalmological drugs and preparations	0.016	0.983	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.016	0.983	0.000
T49.3 Emollients, demulcents and protectants	0.016	0.983	0.000
T49.2 Local astringents and local detergents	0.016	0.983	0.000
T49.1 Antipruritics	0.016	0.983	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.016	0.984	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.016	0.984	0.000
T45.8 Other primarily systemic and haematological agents	0.016	0.984	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.016	0.984	0.000
T45.6 Fibrinolysis-affecting drugs	0.016	0.984	0.000
T45.4 Iron and its compounds	0.016	0.984	0.000
T45.3 Enzymes, not elsewhere classified	0.016	0.984	0.000
T47.6 Antidiarrhoeal drugs	0.016	0.984	0.000
T36.9 Systemic antibiotic, unspecified	0.016	0.984	0.000
T36.7 Antifungal antibiotics, systemically used	0.016	0.984	0.000
T36.6 Rifamycins	0.016	0.984	0.000
T36.5 Aminoglycosides	0.016	0.984	0.000
T36.2 Chloramphenicol group	0.016	0.984	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.016	0.984	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.016	0.984	0.000
T37.5 Antiviral drugs	0.016	0.984	0.000
T37.4 Anthelminthics	0.016	0.984	0.000
T37.3 Other antiprotozoal drugs	0.016	0.984	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.016	0.984	0.000
T37.1 Antimycobacterial drugs	0.016	0.984	0.000
T37.0 Sulphonamides	0.016	0.984	0.000
T39.1 4-Aminophenol derivatives	0.016	0.984	0.000
T40.3 Methadone	0.016	0.984	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.016	0.984	0.000
T40.8 Lysergide [LSD]	0.016	0.984	0.000
T40.7 Cannabis (derivatives)	0.016	0.984	0.000
T40.0 Opium	0.016	0.984	0.000
T46.1 Calcium-channel blockers	0.016	0.984	0.000
T41.5 Therapeutic gases	0.015	0.984	0.000
T41.4 Anaesthetic, unspecified	0.015	0.984	0.000
T41.3 Local anaesthetics	0.015	0.984	0.000
T41.2 Other and unspecified general anaesthetics	0.015	0.984	0.000
T41.1 Intravenous anaesthetics	0.015	0.984	0.000
T41.0 Inhaled anaesthetics	0.015	0.984	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.015	0.984	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.015	0.984	0.000
T47.7 Emetics	0.015	0.984	0.000
T47.5 Digestants	0.015	0.984	0.000
T47.4 Other laxatives	0.015	0.984	0.000
T47.3 Saline and osmotic laxatives	0.015	0.984	0.000
T45.5 Anticoagulants	0.016	0.984	0.000
T36.0 Penicillins	0.015	0.984	0.000
T40.1 Heroin	0.015	0.985	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.985	0.000
T36.3 Macrolides	0.015	0.985	0.000
T47.2 Stimulant laxatives	0.015	0.985	0.000
T42.1 Iminostilbenes	0.015	0.985	0.000
F32 Depressive episode	0.015	0.985	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.014	0.986	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.014	0.986	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.014	0.986	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.014	0.986	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.014	0.986	0.000
T46.7 Peripheral vasodilators	0.014	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.014	0.986	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.014	0.986	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.014	0.986	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.987	0.013
N85.0 Endometrial glandular hyperplasia	0.000	0.987	0.013
T40.5 Cocaine	0.012	0.987	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.013	0.987	0.000
T39.0 Salicylates	0.012	0.988	0.000
F32.0 Mild depressive episode	0.012	0.988	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.012	0.988	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.012	0.988	0.000
G81.9 Hemiplegia, unspecified	0.011	0.989	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.011	0.989	0.000
T40.6 Other and unspecified narcotics	0.010	0.989	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.010	0.990	0.000
F32.8 Other depressive episodes	0.009	0.991	0.000
N85.1 Endometrial adenomatous hyperplasia	0.000	0.991	0.009
N85 Other noninflammatory disorders of uterus, except cervix	0.000	0.991	0.009
T40.2 Other opioids	0.009	0.991	0.000
N85.9 Noninflammatory disorder of uterus, unspecified	0.000	0.992	0.008
N85.4 Malposition of uterus	0.000	0.992	0.008
D04.7 Skin of lower limb, including hip	0.008	0.992	0.000
F32.1 Moderate depressive episode	0.007	0.993	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.007	0.993	0.000
H44.0 Purulent endophthalmitis	0.000	0.993	0.007
K60.0 Acute anal fissure	0.007	0.993	0.000
Q63 Other congenital malformations of kidney	0.007	0.993	0.000
H49.2 Sixth [abducent] nerve palsy	0.000	0.993	0.007
N85.7 Haematometra	0.000	0.993	0.007
Q63.0 Accessory kidney	0.007	0.993	0.000
N85.5 Inversion of uterus	0.000	0.993	0.006
N85.3 Subinvolution of uterus	0.000	0.993	0.006
K60.3 Anal fistula	0.006	0.994	0.000
N85.6 Intra-uterine synechiae	0.000	0.994	0.006
G81 Hemiplegia	0.005	0.994	0.001
F33.9 Recurrent depressive disorder, unspecified	0.006	0.994	0.000
K60 Fissure and fistula of anal and rectal regions	0.006	0.994	0.000
K60.1 Chronic anal fissure	0.006	0.994	0.000
Q63.8 Other specified congenital malformations of kidney	0.006	0.994	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.006	0.994	0.000
O12.0 Gestational oedema	0.006	0.994	0.000
Q63.2 Ectopic kidney	0.005	0.995	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.005	0.995	0.000
Q63.3 Hyperplastic and giant kidney	0.005	0.995	0.000
K60.5 Anorectal fistula	0.005	0.995	0.000
C90.0 Multiple myeloma	0.000	0.995	0.005
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.005	0.995	0.000
G81.1 Spastic hemiplegia	0.004	0.995	0.001
G80.9 Infantile cerebral palsy, unspecified	0.000	0.995	0.005
G81.0 Flaccid hemiplegia	0.004	0.995	0.001
K60.4 Rectal fistula	0.005	0.995	0.000
I69.3 Sequelae of cerebral infarction	0.005	0.995	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.995	0.005
I69 Sequelae of cerebrovascular disease	0.004	0.996	0.000
R47.1 Dysarthria and anarthria	0.004	0.996	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.004	0.996	0.000
M95.0 Acquired deformity of nose	0.004	0.996	0.000
O42.9 Premature rupture of membranes, unspecified	0.000	0.996	0.004
M95.4 Acquired deformity of chest and rib	0.004	0.996	0.000
H49 Paralytic strabismus	0.000	0.996	0.004
N85.2 Hypertrophy of uterus	0.000	0.996	0.004
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.004	0.996	0.000
G80 Infantile cerebral palsy	0.000	0.996	0.004
N64.5 Other signs and symptoms in breast	0.004	0.996	0.000
H49.9 Paralytic strabismus, unspecified	0.000	0.996	0.004
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.004	0.996	0.000
M20.0 Deformity of finger(s)	0.000	0.996	0.004
H49.0 Third [oculomotor] nerve palsy	0.000	0.996	0.004
Z51.3 Blood transfusion without reported diagnosis	0.000	0.996	0.004
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.996	0.004
Z40 Prophylactic surgery	0.000	0.996	0.004
G80.2 Infantile hemiplegia	0.000	0.996	0.004
I69.1 Sequelae of intracerebral haemorrhage	0.004	0.996	0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.004	0.996	0.000
K11.2 Sialoadenitis	0.000	0.996	0.004
G80.0 Spastic cerebral palsy	0.000	0.996	0.003
H49.4 Progressive external ophthalmoplegia	0.000	0.996	0.003
H44 Disorders of globe	0.000	0.996	0.004
M95.3 Acquired deformity of neck	0.003	0.997	0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.997	0.003
D23.6 Skin of upper limb, including shoulder	0.003	0.997	0.000
F32.9 Depressive episode, unspecified	0.003	0.997	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.003	0.997	0.000
H49.3 Total (external) ophthalmoplegia	0.000	0.997	0.003
G80.4 Ataxic cerebral palsy	0.000	0.997	0.003
G80.3 Dyskinetic cerebral palsy	0.000	0.997	0.003
I63 Cerebral infarction	0.003	0.997	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.003	0.997	0.000
G80.8 Other infantile cerebral palsy	0.000	0.997	0.003
H49.1 Fourth [trochlear] nerve palsy	0.000	0.997	0.003
M95.2 Other acquired deformity of head	0.003	0.997	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.003	0.997	0.000
M95.8 Other specified acquired deformities of musculoskeletal system	0.003	0.997	0.000
M95.5 Acquired deformity of pelvis	0.003	0.997	0.000
G80.1 Spastic diplegia	0.000	0.997	0.003
H44.4 Hypotony of eye	0.000	0.997	0.003
H44.1 Other endophthalmitis	0.000	0.997	0.003
O42 Premature rupture of membranes	0.000	0.997	0.003
H44.8 Other disorders of globe	0.000	0.997	0.003
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.003	0.997	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.003	0.997	0.000
M95.1 Cauliflower ear	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.003	0.997	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.000	0.997	0.003
H44.3 Other degenerative disorders of globe	0.000	0.997	0.003
K60.2 Anal fissure, unspecified	0.003	0.997	0.000
O42.2 Premature rupture of membranes, labour delayed by therapy	0.000	0.997	0.003
Q60-Q64 Congenital malformations of the urinary system	0.003	0.997	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.997	0.003
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.000	0.997	0.003
H49.8 Other paralytic strabismus	0.000	0.997	0.002
D04.6 Skin of upper limb, including shoulder	0.003	0.997	0.000
H44.2 Degenerative myopia	0.000	0.997	0.003
Z40.9 Prophylactic surgery, unspecified	0.000	0.997	0.002
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.002	0.997	0.000
G82 Paraplegia and tetraplegia	0.000	0.997	0.003
G82.5 Tetraplegia, unspecified	0.000	0.997	0.003
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.002	0.997	0.000
Z40.8 Other prophylactic surgery	0.000	0.997	0.002
M95.96 Acquired deformity of musculoskeletal system, unspecified	0.002	0.998	0.000
Q64 Other congenital malformations of urinary system	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.000	0.998	0.002
I63.8 Other cerebral infarction	0.002	0.998	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.998	0.002
D04.1 Skin of eyelid, including canthus	0.002	0.998	0.000
H44.9 Disorder of globe, unspecified	0.000	0.998	0.002
G80-G83 Cerebral palsy and other paralytic syndromes	0.000	0.998	0.002
D04.8 Skin of other sites	0.002	0.998	0.000
D04.0 Skin of lip	0.002	0.998	0.000
G82.1 Spastic paraplegia	0.000	0.998	0.002
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
D04.2 Skin of ear and external auricular canal	0.002	0.998	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.002	0.998	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.002	0.998	0.000
D04.9 Skin, unspecified	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.000	0.998	0.002
X65.8 Other specified place	0.002	0.998	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.002	0.998	0.000
Q62.5 Duplication of ureter	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
X60.8 Other specified place	0.002	0.998	0.000
D46.4 Refractory anaemia, unspecified	0.002	0.998	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.002	0.998	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.002	0.998	0.000
C18.1 Appendix	0.002	0.998	0.000
G82.3 Flaccid tetraplegia	0.000	0.998	0.002
G82.0 Flaccid paraplegia	0.000	0.998	0.002
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
G82.4 Spastic tetraplegia	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
Q64.9 Congenital malformation of urinary system, unspecified	0.002	0.998	0.000
Q64.8 Other specified congenital malformations of urinary system	0.002	0.998	0.000
Q64.6 Congenital diverticulum of bladder	0.002	0.998	0.000
Q64.5 Congenital absence of bladder and urethra	0.002	0.998	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.002	0.998	0.000
Q64.2 Congenital posterior urethral valves	0.002	0.998	0.000
Q64.1 Exstrophy of urinary bladder	0.002	0.998	0.000
Q64.0 Epispadias	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.000	0.998	0.002
H31.0 Chorioretinal scars	0.002	0.998	0.000
Q64.4 Malformation of urachus	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
Z80.5 Family history of malignant neoplasm of urinary tract	0.000	0.998	0.002
Q60 Renal agenesis and other reduction defects of kidney	0.002	0.998	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.998	0.002
Q62.8 Other congenital malformations of ureter	0.002	0.998	0.000
Q62.7 Congenital vesico-uretero-renal reflux	0.002	0.998	0.000
Q62.6 Malposition of ureter	0.002	0.998	0.000
Q62.4 Agenesis of ureter	0.002	0.998	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.002	0.998	0.000
Q62.1 Atresia and stenosis of ureter	0.002	0.998	0.000
Q62.0 Congenital hydronephrosis	0.002	0.998	0.000
I62 Other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.998	0.002
G93.6 Cerebral oedema	0.000	0.998	0.002
R74.8 Abnormal levels of other serum enzymes	0.002	0.998	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
X62.9 Unspecified place	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.002	0.998	0.000
I65.2 Occlusion and stenosis of carotid artery	0.002	0.998	0.000
Q62.2 Congenital megaloureter	0.002	0.998	0.000
G83 Other paralytic syndromes	0.000	0.998	0.002
G83.2 Monoplegia of upper limb	0.000	0.998	0.002
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.998	0.002
D46 Myelodysplastic syndromes	0.002	0.998	0.000
I45.6 Preexcitation syndrome	0.000	0.998	0.002
Y45.1 Salicylates	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
S93.0 Dislocation of ankle joint	0.000	0.998	0.002
H31.3 Choroidal haemorrhage and rupture	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
I60-I69 Cerebrovascular diseases	0.002	0.998	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.002	0.998	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.002	0.998	0.000
I62.1 Nontraumatic extradural haemorrhage	0.002	0.998	0.000
E73.9 Lactose intolerance, unspecified	0.002	0.998	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
K11.1 Hypertrophy of salivary gland	0.000	0.998	0.002
K66.8 Other specified disorders of peritoneum	0.000	0.998	0.002
A02.0 Salmonella gastro-enteritis	0.000	0.998	0.002
X50.4 Street and highway	0.002	0.998	0.000
X62.0 Home	0.002	0.998	0.000
X62.7 Farm	0.002	0.998	0.000
X62.6 Industrial and construction area	0.002	0.998	0.000
X62.5 Trade and service area	0.002	0.998	0.000
X62.4 Street and highway	0.002	0.998	0.000
X62.3 Sports and athletics area	0.002	0.998	0.000
X62.2 School, other institution and public administrative area	0.002	0.998	0.000
X62.1 Residential institution	0.002	0.998	0.000
D04.4 Skin of scalp and neck	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.000	0.998	0.002
N34.2 Other urethritis	0.000	0.998	0.002
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
X65.9 Unspecified place	0.002	0.998	0.000
X65.0 Home	0.002	0.998	0.000
X65.7 Farm	0.002	0.998	0.000
X65.6 Industrial and construction area	0.002	0.998	0.000
X65.5 Trade and service area	0.002	0.998	0.000
X65.4 Street and highway	0.002	0.998	0.000
X65.3 Sports and athletics area	0.002	0.998	0.000
X65.2 School, other institution and public administrative area	0.002	0.998	0.000
X65.1 Residential institution	0.002	0.998	0.000
M54.16 Radiculopathy (Lumbar region)	0.000	0.998	0.002
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.998	0.002
C90.1 Plasma cell leukaemia	0.000	0.998	0.002
Q60.6 Potter's syndrome	0.002	0.998	0.000
Q60.5 Renal hypoplasia, unspecified	0.002	0.998	0.000
Q60.4 Renal hypoplasia, bilateral	0.002	0.998	0.000
Q60.3 Renal hypoplasia, unilateral	0.002	0.998	0.000
Q60.1 Renal agenesis, bilateral	0.002	0.998	0.000
R87.7 Abnormal histological findings	0.002	0.998	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.002	0.998	0.000
X84.0 Home	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
D46.1 Refractory anaemia with sideroblasts	0.002	0.998	0.000
I61.8 Other intracerebral haemorrhage	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
C25.0 Head of pancreas	0.002	0.998	0.000
Q60.0 Renal agenesis, unilateral	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.002	0.998	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.002	0.998	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.002	0.998	0.000
G83.5 Locked-in syndrome	0.000	0.998	0.001
G83.3 Monoplegia, unspecified	0.000	0.998	0.001
G83.0 Diplegia of upper limbs	0.000	0.998	0.001
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.002	0.998	0.000
X69.9 Unspecified place	0.002	0.998	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.002	0.998	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.998	0.002
D46.5 Refractory anaemia with multi-lineage dysplasia	0.002	0.998	0.000
G83.8 Other specified paralytic syndromes	0.000	0.998	0.002
I65.0 Occlusion and stenosis of vertebral artery	0.002	0.998	0.000
V48.4 Person injured while boarding or alighting	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
M79.4 Hypertrophy of (infrapatellar) fat pad	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.998	0.000
X79 Intentional self-harm by blunt object	0.001	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.998	0.000
X75 Intentional self-harm by explosive material	0.001	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.001	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.998	0.001
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.002	0.998	0.000
X61.4 Street and highway	0.001	0.998	0.000
X70.2 School, other institution and public administrative area	0.001	0.998	0.000
I61 Intracerebral haemorrhage	0.002	0.998	0.000
D46.2 Refractory anaemia with excess of blasts	0.001	0.998	0.000
G83.4 Cauda equina syndrome	0.000	0.998	0.002
I45.8 Other specified conduction disorders	0.000	0.998	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.001	0.998	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.001	0.998	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
B19.9 Unspecified viral hepatitis without coma	0.001	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
H31 Other disorders of choroid	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.001	0.998	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
X60.09 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics; Home; During unspecified activity	0.001	0.998	0.000
X60.08 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Home , While engaged in other specified activities	0.001	0.998	0.000
X60.99 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Unspecified place, During unspecified activity	0.001	0.998	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.001	0.998	0.000
X65.09 Intentional self-poisoning by and exposure to alcohol, Home, During unspecified activity	0.001	0.998	0.000
X65.99 Intentional self-poisoning by and exposure to alcohol, Unspecified place, During unspecified activity	0.001	0.998	0.000
X65.98 Intentional self-poisoning by and exposure to alcohol; Unspecified place ;While engaged in other specified activities	0.001	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.001	0.998	0.000
S06.2 Diffuse brain injury	0.001	0.998	0.000
G57.6 Lesion of plantar nerve	0.000	0.998	0.002
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.998	0.001
Q60.2 Renal agenesis, unspecified	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations